Associate Director of Advocacy & PLC Integrations IDEXX Simpsonville, South Carolina, United States
Disclosure(s):
Rebekah Mack, DVM, DACVIM-SAIM, MSEd (Candidate): No financial relationships to disclose
Active and Acute kidney injury is recognized as a proven contributor to clinical complications and worsened prognosis in patients. In this discussion case examples and review of interpretation and clinical workflow for the active injury marker Cystatin B will be presented.
Learning Objectives:
Understand appropriate clinical application and interpretation of Cystatin B
Apply case examples to understand patient profiles important for inclusion of testing
